Compare Mutual Funds
Pros | - | Among most bought funds within the category. Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | - | 8/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 4 Years 7 Months | 13 Years 7 Months | ||
Fund AUM | ₹238 Cr | ₹8636 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 3.11% | 0.8% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 41 | 37 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 4 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.25% | 97.92% | ||
Debt % | - | - | ||
P/E | 41.02 | 36.71 | ||
P/B | 5.62 | 5.41 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.49% | -1.52% | ||
3-Month Return | 10.68% | 6.84% | ||
6-Month Return | 5.87% | 5.41% | ||
1-Year Return | 3.91% | 5.3% | ||
3-Year Return | 20.79% | 21.89% | ||
5-Year Return | - | 13.44% |
Sharpe | 0.91 | 1.03 | ||
Alpha | -0.54 | -0.47 | ||
Beta | 0.93 | 0.9 | ||
Standard Deviation | 16.79 | 15.79 | ||
Information Ratio | -0.37 | -0.65 |
Description | ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Animesh Singh, Nilay Dalal | Sailesh Raj Bhan, Amber Singhania, Kinjal Desai |

